Cocrystal Pharma Statistics
Total Valuation
COCP has a market cap or net worth of $19.07 million. The enterprise value is $15.45 million.
| Market Cap | 19.07M |
| Enterprise Value | 15.45M |
Important Dates
The last earnings date was Sunday, November 15, 2026, before market open.
| Earnings Date | Nov 15, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
COCP has 19.26 million shares outstanding. The number of shares has increased by 41.73% in one year.
| Current Share Class | 19.26M |
| Shares Outstanding | 19.26M |
| Shares Change (YoY) | +41.73% |
| Shares Change (QoQ) | +26.33% |
| Owned by Insiders (%) | 24.42% |
| Owned by Institutions (%) | 6.00% |
| Float | 14.56M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 43.40 |
| Forward PS | n/a |
| PB Ratio | 7.06 |
| P/TBV Ratio | 7.06 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 35.09 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.72, with a Debt / Equity ratio of 0.47.
| Current Ratio | 1.72 |
| Quick Ratio | 1.57 |
| Debt / Equity | 0.47 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -219.12% and return on invested capital (ROIC) is -109.13%.
| Return on Equity (ROE) | -219.12% |
| Return on Assets (ROA) | -83.56% |
| Return on Invested Capital (ROIC) | -109.13% |
| Return on Capital Employed (ROCE) | -322.32% |
| Weighted Average Cost of Capital (WACC) | 12.30% |
| Revenue Per Employee | $43,500 |
| Profits Per Employee | -$1.13M |
| Employee Count | 10 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -7.77% in the last 52 weeks. The beta is 1.61, so COCP's price volatility has been higher than the market average.
| Beta (5Y) | 1.61 |
| 52-Week Price Change | -7.77% |
| 50-Day Moving Average | 1.08 |
| 200-Day Moving Average | 1.10 |
| Relative Strength Index (RSI) | 40.31 |
| Average Volume (20 Days) | 27,430 |
Short Selling Information
The latest short interest is 181,361, so 0.94% of the outstanding shares have been sold short.
| Short Interest | 181,361 |
| Short Previous Month | 179,193 |
| Short % of Shares Out | 0.94% |
| Short % of Float | 1.25% |
| Short Ratio (days to cover) | 5.06 |
Income Statement
In the last 12 months, COCP had revenue of $435,000 and -$11.33 million in losses. Loss per share was -$0.77.
| Revenue | 435,000 |
| Gross Profit | -4.62M |
| Operating Income | -11.51M |
| Pretax Income | -11.33M |
| Net Income | -11.33M |
| EBITDA | -11.46M |
| EBIT | -11.51M |
| Loss Per Share | -$0.77 |
Balance Sheet
The company has $4.87 million in cash and $1.26 million in debt, with a net cash position of $3.62 million or $0.19 per share.
| Cash & Cash Equivalents | 4.87M |
| Total Debt | 1.26M |
| Net Cash | 3.62M |
| Net Cash Per Share | $0.19 |
| Equity (Book Value) | 2.68M |
| Book Value Per Share | 0.14 |
| Working Capital | 2.31M |
Cash Flow
In the last 12 months, operating cash flow was -$7.95 million and capital expenditures -$12,000, giving a free cash flow of -$7.97 million.
| Operating Cash Flow | -7.95M |
| Capital Expenditures | -12,000 |
| Depreciation & Amortization | 49,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -7.97M |
| FCF Per Share | -$0.41 |
Margins
| Gross Margin | n/a |
| Operating Margin | -2,645.98% |
| Pretax Margin | -2,605.29% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
COCP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -41.73% |
| Shareholder Yield | -41.73% |
| Earnings Yield | -77.81% |
| FCF Yield | -42.19% |
Analyst Forecast
The average price target for COCP is $8.00, which is 708.08% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.00 |
| Price Target Difference | 708.08% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on October 11, 2022. It was a reverse split with a ratio of 1:12.
| Last Split Date | Oct 11, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:12 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |